IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,210,809 | -25.3% | 312,347 | -13.7% | 0.01% | -14.3% |
| Q2 2023 | $21,703,301 | +20.1% | 361,963 | -1.0% | 0.01% | +16.7% |
| Q1 2023 | $18,074,374 | -13.5% | 365,582 | -0.1% | 0.01% | -14.3% |
| Q4 2022 | $20,883,853 | +22.0% | 365,934 | +0.3% | 0.01% | +16.7% |
| Q3 2022 | $17,121,000 | +35.0% | 364,738 | +7.3% | 0.01% | +50.0% |
| Q2 2022 | $12,683,000 | +23.9% | 339,942 | -0.7% | 0.00% | +33.3% |
| Q1 2022 | $10,240,000 | -10.2% | 342,478 | +2.8% | 0.00% | 0.0% |
| Q4 2021 | $11,405,000 | -8.3% | 333,080 | -0.7% | 0.00% | -25.0% |
| Q3 2021 | $12,437,000 | +227.5% | 335,512 | +245.1% | 0.00% | +300.0% |
| Q2 2021 | $3,797,000 | -8.5% | 97,226 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $4,151,000 | – | 97,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |